Abstract
Understanding the ability of SARS-CoV-2 vaccine-elicited antibodies to neutralize and protect against emerging variants of concern and other sarbecoviruses is key for guiding vaccine development decisions and public health policies....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have